![]() |
Volumn 3, Issue 3, 2006, Pages 116-117
|
Does cannabis hold the key to treating cardiometabolic disease?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADIPONECTIN;
C REACTIVE PROTEIN;
CANNABINOID 1 RECEPTOR;
CANNABINOID 2 RECEPTOR;
CANNABINOID RECEPTOR AGONIST;
CANNABINOID RECEPTOR ANTAGONIST;
CANNABIS;
DRONABINOL;
ENDOCANNABINOID;
RIMONABANT;
ANTIINFLAMMATORY ACTIVITY;
ATHEROGENESIS;
ATHEROSCLEROSIS;
CARDIOVASCULAR DISEASE;
CLINICAL TRIAL;
DRUG BLOOD LEVEL;
DRUG MECHANISM;
DYSLIPIDEMIA;
HUMAN;
HYPERTENSION;
IMMUNE RESPONSE;
INSULIN RESISTANCE;
LOW CALORY DIET;
METABOLIC DISORDER;
METABOLIC SYNDROME X;
NONHUMAN;
OBESITY;
PRIORITY JOURNAL;
REVIEW;
SMOKING CESSATION;
TREATMENT OUTCOME;
VASCULITIS;
CANNABIS;
CARDIOVASCULAR DISEASES;
HUMANS;
METABOLIC SYNDROME X;
PHYTOTHERAPY;
PLANT PREPARATIONS;
TREATMENT OUTCOME;
|
EID: 33644593422
PISSN: 17434297
EISSN: None
Source Type: Journal
DOI: 10.1038/ncpcardio0504 Document Type: Review |
Times cited : (5)
|
References (9)
|